Synthesis and testing of peptides for anti-prion activity

Shane Sellarajah, Cyrille Boussard, Tamuna Lekishvili, David R Brown, Ian H Gilbert

Research output: Contribution to journalArticle

  • 3 Citations

Abstract

Creutzfeldt–Jakob disease (CJD) is one of the fatal transmissible spongiform encephalopathies for which there is no known cure. The disease is associated with an abnormally folded prion protein, PrP-res, which is thought to form due to interaction between normal prion PrPC and PrP-res. Small peptides were designed to prevent this interaction. A structure–activity relationship is described for a series of peptides which were synthesised and tested for their activity against two prion disease model assays, an in vitro cellular assay and an in vitro anti-aggregation polymerisation assay. A number of peptides were found to be active at levels of 100 μM. New libraries were synthesised in order to concentrate on discovering new, shorter peptides which could be leads for developing peptidomimetics.
LanguageEnglish
Pages2418-2427
Number of pages10
JournalEuropean Journal of Medicinal Chemistry
Volume43
Issue number11
DOIs
StatusPublished - Nov 2008

Fingerprint

Prions
PrPSc Proteins
Assays
Peptides
Prion Diseases
Testing
Peptidomimetics
Creutzfeldt-Jakob Syndrome
Structure-Activity Relationship
Polymerization
Libraries
Agglomeration
In Vitro Techniques

Cite this

Sellarajah, S., Boussard, C., Lekishvili, T., Brown, D. R., & Gilbert, I. H. (2008). Synthesis and testing of peptides for anti-prion activity. European Journal of Medicinal Chemistry, 43(11), 2418-2427. DOI: 10.1016/j.ejmech.2008.01.041

Synthesis and testing of peptides for anti-prion activity. / Sellarajah, Shane; Boussard, Cyrille; Lekishvili, Tamuna; Brown, David R; Gilbert, Ian H.

In: European Journal of Medicinal Chemistry, Vol. 43, No. 11, 11.2008, p. 2418-2427.

Research output: Contribution to journalArticle

Sellarajah, S, Boussard, C, Lekishvili, T, Brown, DR & Gilbert, IH 2008, 'Synthesis and testing of peptides for anti-prion activity' European Journal of Medicinal Chemistry, vol. 43, no. 11, pp. 2418-2427. DOI: 10.1016/j.ejmech.2008.01.041
Sellarajah S, Boussard C, Lekishvili T, Brown DR, Gilbert IH. Synthesis and testing of peptides for anti-prion activity. European Journal of Medicinal Chemistry. 2008 Nov;43(11):2418-2427. Available from, DOI: 10.1016/j.ejmech.2008.01.041
Sellarajah, Shane ; Boussard, Cyrille ; Lekishvili, Tamuna ; Brown, David R ; Gilbert, Ian H. / Synthesis and testing of peptides for anti-prion activity. In: European Journal of Medicinal Chemistry. 2008 ; Vol. 43, No. 11. pp. 2418-2427
@article{31fc22757ae74a94b7c391ae17423230,
title = "Synthesis and testing of peptides for anti-prion activity",
abstract = "Creutzfeldt–Jakob disease (CJD) is one of the fatal transmissible spongiform encephalopathies for which there is no known cure. The disease is associated with an abnormally folded prion protein, PrP-res, which is thought to form due to interaction between normal prion PrPC and PrP-res. Small peptides were designed to prevent this interaction. A structure–activity relationship is described for a series of peptides which were synthesised and tested for their activity against two prion disease model assays, an in vitro cellular assay and an in vitro anti-aggregation polymerisation assay. A number of peptides were found to be active at levels of 100 μM. New libraries were synthesised in order to concentrate on discovering new, shorter peptides which could be leads for developing peptidomimetics.",
author = "Shane Sellarajah and Cyrille Boussard and Tamuna Lekishvili and Brown, {David R} and Gilbert, {Ian H}",
year = "2008",
month = "11",
doi = "10.1016/j.ejmech.2008.01.041",
language = "English",
volume = "43",
pages = "2418--2427",
journal = "European Journal of Medicinal Chemistry",
issn = "0223-5234",
publisher = "Elsevier Masson SAS",
number = "11",

}

TY - JOUR

T1 - Synthesis and testing of peptides for anti-prion activity

AU - Sellarajah,Shane

AU - Boussard,Cyrille

AU - Lekishvili,Tamuna

AU - Brown,David R

AU - Gilbert,Ian H

PY - 2008/11

Y1 - 2008/11

N2 - Creutzfeldt–Jakob disease (CJD) is one of the fatal transmissible spongiform encephalopathies for which there is no known cure. The disease is associated with an abnormally folded prion protein, PrP-res, which is thought to form due to interaction between normal prion PrPC and PrP-res. Small peptides were designed to prevent this interaction. A structure–activity relationship is described for a series of peptides which were synthesised and tested for their activity against two prion disease model assays, an in vitro cellular assay and an in vitro anti-aggregation polymerisation assay. A number of peptides were found to be active at levels of 100 μM. New libraries were synthesised in order to concentrate on discovering new, shorter peptides which could be leads for developing peptidomimetics.

AB - Creutzfeldt–Jakob disease (CJD) is one of the fatal transmissible spongiform encephalopathies for which there is no known cure. The disease is associated with an abnormally folded prion protein, PrP-res, which is thought to form due to interaction between normal prion PrPC and PrP-res. Small peptides were designed to prevent this interaction. A structure–activity relationship is described for a series of peptides which were synthesised and tested for their activity against two prion disease model assays, an in vitro cellular assay and an in vitro anti-aggregation polymerisation assay. A number of peptides were found to be active at levels of 100 μM. New libraries were synthesised in order to concentrate on discovering new, shorter peptides which could be leads for developing peptidomimetics.

UR - http://www.scopus.com/inward/record.url?scp=54049098830&partnerID=8YFLogxK

UR - http://dx.doi.org/10.1016/j.ejmech.2008.01.041

U2 - 10.1016/j.ejmech.2008.01.041

DO - 10.1016/j.ejmech.2008.01.041

M3 - Article

VL - 43

SP - 2418

EP - 2427

JO - European Journal of Medicinal Chemistry

T2 - European Journal of Medicinal Chemistry

JF - European Journal of Medicinal Chemistry

SN - 0223-5234

IS - 11

ER -